SCHEMBL7931029

SCHEMBL7931029

CC(C)C[C@@H](C(=O)NN(CC(C)C)C(=O)C(F)(F)F)[C@H](CC=Cc1ccccc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 3/20 0.57
GRIK1 P39086 3/20 0.37
GRIK2 Q13002 3/20 0.37
HTR2A P28223 3/20 0.34
CTSC P53634 1/20 0.34
MMP2 P08253 5/20 0.33
MMP3 P08254 4/20 0.33
MMP7 P09237 3/20 0.33
LTA4H P09960 1/20 0.33
ANPEP P15144 1/20 0.33
MMP1 P03956 4/20 0.33
MMP8 P22894 3/20 0.33
MMP9 P14780 2/20 0.33
MMP13 P45452 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP12 P39900 1/20 0.33
MMP14 P50281 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943851 0.93 ADAM17 (0.67) ADAM17MMP2MMP3MMP7MMP1
SCHEMBL6986274 0.89 ADAM17 (0.52) ADAM17GRIK1GRIK2
SCHEMBL6945913 0.87 ADAM17 (0.63) ADAM17GRIK1GRIK2HTR2ACTSC
SCHEMBL6939982 0.86 ADAM17 (0.59) ADAM17GRIK1GRIK2HTR2ACTSC
SCHEMBL7930987 0.82 ADAM17 (0.55) ADAM17GRIK1GRIK2HTR2ACTSC
SCHEMBL8097968 0.81 ADAM17 (0.73) ADAM17MMP2MMP3MMP7LTA4H
SCHEMBL6942575 0.81 ADAM17 (0.73) ADAM17MMP2MMP3MMP7LTA4H
SCHEMBL6942562 0.81 ADAM17 (0.73) ADAM17MMP2MMP3MMP7LTA4H
SCHEMBL6942567 0.81 ADAM17 (0.73) ADAM17MMP2MMP3MMP7LTA4H
SCHEMBL6984060 0.81 ADAM17 (0.47) ADAM17CTSCMMP2LTA4HANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265446-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES HOFFMANN-LA ROCHE INC.. 2001-07-24 US disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed